(1)
Bevan, G.; Hood, C. What’s Measured Is What Matters: Targets and Gaming in the English Public Health Care System. Public Administration 2006, 84 (3), 517–538. https://doi.org/10.1111/j.1467-9299.2006.00600.x.
(2)
Raanan Gillon. Medical Ethics: Four Principles Plus Attention To Scope. BMJ: British Medical Journal 1994, 309 (6948), 184–188.
(3)
Walshe, K. Regulating Healthcare: A Prescription for Improvement?; Open University Press: Maidenhead, 2003.
(4)
London School of Economics and Political Science. The LSE Companion to Health Policy; McGuire, A., Costa-i-Font, J., Eds.; Edward Elgar: Cheltenham, UK, 2012.
(5)
Jerak-Zuiderent, S.; Bal, R. Locating the Worths of Performance Indicators: Performing Transparencies and Accountabilities in Health Care. In The mutual construction of statistics and society; Routledge: New York, NY, 2011; Vol. Routledge advances in research methods, pp 224–242.
(6)
Bovens, M.; Schillemans, T.; Hart, P. Does Public Accountability Work? An Assessment Tool. Public Administration 2008, 86 (1), 225–242. https://doi.org/10.1111/j.1467-9299.2008.00716.x.
(7)
Boxall, A.-M.; Buckmaster, L. Options for Reforming Australia’s Health System – Parliament of Australia, 2009.
(8)
Australia. Parliament. House of Representatives. Standing Committee on Health and Ageing. The Blame Game: Report on the Inquiry into Health Funding, 2006.
(9)
Organisation for Economic Co-operation and Development. OECD Reviews of Health Care Quality: Australia 2015: Raising Standards; OECD Publishing: Paris, 2015.
(10)
Commonwealth of Australia. Reform of the Federation White Paper: Issues Paper 3. Roles and Responsibilities in Health, 2014.
(11)
Sinha, S. Samir Sinha on Whether the Aging Population Will Bankrupt the Health Care System, 2011.
(12)
Bloom, D. E.; Chatterji, S.; Kowal, P.; Lloyd-Sherlock, P.; McKee, M.; Rechel, B.; Rosenberg, L.; Smith, J. P. Macroeconomic Implications of Population Ageing and Selected Policy Responses. The Lancet 2015, 385 (9968), 649–657. https://doi.org/10.1016/S0140-6736(14)61464-1.
(13)
Prince, M. J.; Wu, F.; Guo, Y.; Gutierrez Robledo, L. M.; O’Donnell, M.; Sullivan, R.; Yusuf, S. The Burden of Disease in Older People and Implications for Health Policy and Practice. The Lancet 2015, 385 (9967), 549–562. https://doi.org/10.1016/S0140-6736(14)61347-7.
(14)
Kickbusch, I.; McCann, W.; Sherbon, T. Adelaide Revisited: From Healthy Public Policy to Health in All Policies. Health Promotion International 2008, 23 (1), 1–4. https://doi.org/10.1093/heapro/dan006.
(15)
Marmot, M. The Health Gap: The Challenge of an Unequal World; Bloomsbury: London, 2015.
(16)
McCracken, K.; Phillips, D. R. Global Health : An Introduction to Current and Future Trends. Chapter 3: The Determinants of Population Health. In Global health: an introduction to current and future trends; Routledge: Milton Park, [England], 2012; pp 42–52.
(17)
OECD. Health Policy Overview: Health Policy in Australia, 2015.
(18)
Marmot, M. 2016 Boyer Lecture Series. Health inequality and the causes of the causes. http://www.abc.net.au/radionational/programs/boyerlectures/.
(19)
South Australian Government’s Community Engagement Strategy. Principles of Engagement Video, 2013.
(20)
House of Commons Health Committee. The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004–05, 2005.
(21)
Lavis, J. N.; Posada, F. B.; Haines, A.; Osei, E. Use of Research to Inform Public Policymaking. The Lancet 2004, 364 (9445), 1615–1621. https://doi.org/10.1016/S0140-6736(04)17317-0.
(22)
Whitely, M. Licensing and Subsidising Pharmaceuticals in Australia - Reforms Needed to Deliver Transparency, Safety, and Value for Money: Health Consumers’ Council Submission to The Senate Select Committee on Health” Health Consumers, 2014.
(23)
Wishart, A. Adam Wishart (documentary): The price of life: should we as a nation pay for high price cancer drugs?. http://www.adamwishart.info/the-price-of-life/.
(24)
House of Commons Health Committee. The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004–05, 2005.
(25)
Duckett, S. Australia’s Bad Drug Deal: High Pharmaceutical Prices, 2013.
(26)
A Message From The PM - Cutting Red Tape, 15AD.
(27)
Weir, M.; Wardle, J.; Marshall, B.; Archer, E. Regulation of Complementary and Alternative Medicine: Interplay of Therapeutic Goods Legislation and Consumer Law. Bond Law Review 2013, 25 (1), 13–34.
(28)
Therapeutic Goods Administration. Presentation: Therapeutic Goods Administration - An introduction to the work of Australia’s regulator of therapeutic goods. https://www.tga.gov.au/introduction-tga.
(29)
Australian National Audit Office (ANAO). Administering Regulation: Achieving the Right Balance: Better Practice Guide, Part 2 (Key Regulatory Activities), 2014.
(30)
Buse, K.; Mays, N.; Walt, G. Chapter 1: Making Health Policy. In Making Health Policy (Understanding Public Health); Open University Press, 2005; pp 4–19.
(31)
Sansom, L.; Delaat, W.; Horvath, J. Independent Review of Medicines and Medical Devices: Report to the Minister for Health, 2015.
(32)
Walshe, K. Regulating Healthcare: A Prescription for Improvement?; Open University Press: Maidenhead, 2003.
(33)
Akenroye, T. O. Factors Influencing Innovation in Healthcare: A Conceptual Synthesis. The Innovation Journal; Ottawa 2012, 17 (2), 1–21.
(34)
HealthcareCan. Driving Innovation in Healthcare: An Engine for Economic Growth and Prosperity: Speaking Notes for Pre-Budget Meeting with Minister of Finance, 2016.
(35)
Luft, H. S. Economic Incentives to Promote Innovation in Healthcare Delivery. Clinical Orthopaedics and Related Research® 2009, 467 (10), 2497–2505. https://doi.org/10.1007/s11999-009-0930-7.
(36)
Omachonu, V. K.; Einspruch, N. G. Innovation in Healthcare Delivery Systems: A Conceptual Framework. The innovation journal 2010, 15 (1), 1–20.
(37)
Thakur, R.; Hsu, S. H. Y.; Fontenot, G. Innovation in Healthcare: Issues and Future Trends. Journal of Business Research 2012, 65 (4), 562–569. https://doi.org/10.1016/j.jbusres.2011.02.022.
(38)
State of Victoria. Critical success factors: how to establish a successful telehealth service. https://www2.health.vic.gov.au/hospitals-and-health-services/rural-health/telehealth/about-telehealth.
(39)
Bill Gates: The next Outbreak? We’re Not Ready | TED Talk.
(40)
Ebola Reflections: Them, Not Us | Javid Abdelmoneim | TEDxAthens, 30AD.
(41)
Batniji, R.; Songane, F. Contemporary Global Health Governance: Origins, Functions, and Challenges. In The handbook of global health policy; Brown, G. W., Yamey, G., Wamala, S. P., Eds.; Wiley-Blackwell: Chichester, England, 2014; pp 63–76.
(42)
Bonita, R.; Irwin, A.; Beaglehole, R. Promoting Public Health in the Twenty-First Century: The Role of the World Health Organization. In Globalization and health; Oxford University Press: Oxford, 2007; pp 3–17.
(43)
Brown, G. W.; Yamey, G.; Wamala, S. P. The Handbook of Global Health Policy. Introduction. In The handbook of global health policy; Brown, G. W., Yamey, G., Wamala, S. P., Eds.; Wiley-Blackwell: Chichester, England, 2014; pp 1–18.
(44)
Brugha, R.; Bruen, C.; Tangcharoensathien, V. Understanding Global Health Policy. In The handbook of global health policy; Brown, G. W., Yamey, G., Wamala, S. P., Eds.; Wiley-Blackwell: Chichester, England, 2014; pp 21–46.
(45)
Duten, A. J. Global Health Diplomacy: Concepts, Issues, Actors, Instruments, Fora and Cases. Medicine, Conflict and Survival 2015, 31 (2), 127–128. https://doi.org/10.1080/13623699.2014.988406.
(46)
McCracken, K.; Phillips, D. R. Global Health : An Introduction to Current and Future Trends. Chapter 10. In Global health: an introduction to current and future trends; Routledge: Milton Park, [England], 2012; pp 239–255.
(47)
Rushton, S. Arguments for Securitizing Global Health Priorities. In The handbook of global health policy; Brown, G. W., Yamey, G., Wamala, S. P., Eds.; Wiley-Blackwell: Chichester, England, 2014; pp 289–304.
(48)
Schrecker, T.; Labonte, R. What’s Politics Got to Do with It? Health, the G8, and the Global Economy. In Globalization and health; Oxford University Press: Oxford, 2007; pp 284–310.
(49)
Walt, G.; Shiffman, J.; Schneider, H.; Murray, S. F.; Brugha, R.; Gilson, L. ‘Doing’ Health Policy Analysis: Methodological and Conceptual Reflections and Challenges. Health Policy and Planning 2008, 23 (5), 308–317. https://doi.org/10.1093/heapol/czn024.
(50)
The Commonwealth Fund. International Profiles of Health Care Systems. http://www.commonwealthfund.org/publications/fund-reports/2016/jan/international-profiles-2015.
(51)
Japan: Universal Health Care at 50 Years. http://www.thelancet.com/series/japan.
(52)
Arab world: health in the Arab world - a view from within. http://www.thelancet.com/series/health-in-the-arab-world.
(53)
Barr, M. Chapter 7: Singapore. In Comparative health policy in the Asia-Pacific; Open University Press: Maidenhead, Berkshire, 2005; pp 146–173.
(54)
Blank, R. H.; Burau, V. D. Comparative Health Policy; Palgrave Macmillan: Houndmills, Basingstoke, 2004.
(55)
Kronfol, N. M. Delivery of Health Services in Arab Countries: A Review/Prestation de Services de Sante Dans Les Pays Arabes: Revue. Eastern Mediterranean Health Journal 2012, 18 (12).
(56)
Lewis, M. J.; Macpherson, K. L. Public Health in Asia and the Pacific: Historical and Comparative Perspectives; Routledge: London, 2008; Vol. Routledge advances in Asia-Pacific studies.
(57)
Tenbensel, T. Complexity in Health and Health Care Systems. Social Science & Medicine 2013, 93, 181–184. https://doi.org/10.1016/j.socscimed.2013.06.017.
(58)
Bloom, B. R.; Marcuse, E.; Mnookin, S. Addressing Vaccine Hesitancy. Science 2014, 344 (6182), 339–339. https://doi.org/10.1126/science.1254834.
(59)
Attwell, K.; Freeman, M. I Immunise: An Evaluation of a Values-Based Campaign to Change Attitudes and Beliefs. Vaccine 2015, 33 (46), 6235–6240. https://doi.org/10.1016/j.vaccine.2015.09.092.
(60)
Glasgow, R. E.; Emmons, K. M. How Can We Increase Translation of Research into Practice? Types of Evidence Needed. Annual Review of Public Health 2007, 28 (1), 413–433. https://doi.org/10.1146/annurev.publhealth.28.021406.144145.
(61)
Omachonu, V. K.; Einspruch, N. G. Innovation in Healthcare Delivery Systems: A Conceptual Framework. Innovation Journal 2010, 15 (1), 2–20.
(62)
RTI International–University of North Carolina; Agency for Healthcare Research and Quality. Medicines to Treat Alcohol Use Disorder a Review of the Research for Adults, 2016.
(63)
RTI International–University of North Carolina; Agency for Healthcare Research and Quality. Pharmacotherapy for Adults with Alcohol Use Disorder in Outpatient Settings, 2016.
(64)
Chalmers, I.; Bracken, M. B.; Djulbegovic, B.; Garattini, S.; Grant, J.; Gülmezoglu, A. M.; Howells, D. W.; Ioannidis, J. P. A.; Oliver, S. How to Increase Value and Reduce Waste When Research Priorities Are Set. The Lancet 2014, 383 (9912), 156–165. https://doi.org/10.1016/S0140-6736(13)62229-1.
(65)
Giles, C. Five tips on how the NHS can engage patients and the public. https://www.theguardian.com/healthcare-network/2014/oct/29/how-nhs-engage-patients-public.
(66)
Berry, S. M.; Connor, J. T.; Lewis, R. J. The Platform Trial. JAMA 2015, 313 (16). https://doi.org/10.1001/jama.2015.2316.
(67)
Isaacs, D. Seven Alternatives to Evidence Based Medicine. BMJ : British Medical Journal 1999, 319 (7225).
(68)
Rose, D. Patient and Public Involvement in Health Research: Ethical Imperative and/or Radical Challenge? Journal of Health Psychology 2014, 19 (1), 149–158. https://doi.org/10.1177/1359105313500249.
(69)
Webb, S.; Zeps, N. Integrating Research into Healthcare: Making It Ethical by Design. Medicus 2014, 54 (1), 26–27.
